Dana-Farber’s Breast Oncology Center shared a post on X:
“This just published international cohort study called INCORPORATE looked at immune checkpoint inhibitors for patients with metastatic triple-negative Inflammatory Breast Cancer.
Read it here for free until December 20.”
